drugset / Trial / NCT01972880

A Study to Compare the Oral Absorption of ASP1941 Among Two Types of Tablets

NCT01972880

Phase 1 Completed 32 enrolled Astellas Pharma Inc
RandomizedCrossoverOpen-label

Summary

To assess the bioequivalence of a single dose of ASP1941 between tablet-1 and tablet-2 in a two-way crossover method in non-elderly healthy male subjects. In addition, the safety of these products will be assessed.

Timeline

Start
2013-09
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject ipragliflozin Small molecule Oral

Indications

No indication recorded.